One of India’s biggest neutraceuticals and health-food brands, Dabur, has clarified that it was not aware of exports of its products from India to the USA, leading to a US FDA alert.
Media reports had said that the U.S. Food and Drug Administration, the agency that approves drugs and medicines and maintains quality of packaged foods, raised alerts about the quality of Dabur’s products being sold in the country.
The standards in the United States are usually higher than those in India, Dabur’s main market.
“The products were part of an unauthorized export by an independent trader without any consent or knowledge of Dabur India Ltd. Dabur does not export its products from India to the US. Dabur has already taken up the matter with the US FDA,” it said in a statement.
Many Indian Ayurvedic products have fallen foul of norms in countries like the U.S.. Some of these formulations have previously been flagged for containing too much metal etc..
Ayurvedic foods and medicines are made from herbs and animal products as prescribed in ancient Indian texts like Charaka Samhita and Susruta Samhita.